Handmade quality · Free shipping over $75 · Explore the atelier

BGB-283 ide Rb3 A combinatorial strategy for treating

SKU: 76924808975

4.8
USD100.00 USD144.00

Pay in 4 interest-free payments of $25.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

A combinatorial strategy for treating KRAS-mutant lung cancer

Formula: C18H24N2OS

Novaluron is an insect growth regulator that is used against many field pests on corn

SAR131675 is the first highly specific VEGFR-3-TK inhibitor described to date

BGB-283 ide Rb3 A combinatorial strategy for treatingBGB 283 is a novel and potent Raf Kinase and EGFR inhibitor with IC50 values of 23 and 29 nM for recombinant BRafV600E and EGFR, respectively. BGB 283 potently inhibits BRafV600E activated ERK phosphorylation and cell proliferation. It demonstrates selective cytotoxicity and preferentially inhibits proliferation of cancer cells harboring BRafV600E and EGFR mutation amplification. In BRafV600E colorectal cancer cell lines, BGB 283 effectively inhibits

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products